palatal donor site for gingival graft. Donor of other specified organs or tissues
Conditions
Interventions
Intervention 1: Intervention group: Patients with mucogingival defects requiring gingival graft surgery will receive a composite dressing in combination with a resorbable collagen sponge to control bl
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with mucogingival defects (including lack of keratinized gingival width, gingival recession, insufficient vestibular depth) around teeth and implants, who require gum grafting surgery. The minimum thickness of the patient's palatal soft tissue should be 2 mm. The minimum height of patient's palatal vault should be 12 mm.
Exclusion criteria
Exclusion criteria: The presence of debilitating systemic disease, coagulation disorders, or any disease that has a significant impact on periodontal tissues (such as diabetes) Patients with known allergy to any of the materials used in the study Patients with gagging reflex patients with ongoing orthodontic treatment with palatal appliance Patients who wear maxillary dentures or overdentures that cover the palatal area. Patients with history of previous palatal soft tissue harvesting Presence of oral lesions in the palate Inability to maintain oral hygiene with at least 80% of plaque-free surfaces. Smoking and alcohol consumption.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pain. Timepoint: Daily during the first 7 days and on day 14 postoperatively. Method of measurement: Using the patient-reported Visual Analog Scale and the amount of ibuprofen consumed (in milligrams). | — |
Secondary
| Measure | Time frame |
|---|---|
| Donor site working time. Timepoint: during surgical process. Method of measurement: with stopwatch.;Presence and severity of post surgical delayed bleeding. Timepoint: Daily for the first 7 days post surgical. Method of measurement: Patient-reported Visual Analogue Scale.;Postoperative complications ( including necrosis, infection, and hematoma) in the palatal donor site. Timepoint: on day 7 post surgical. Method of measurement: visual clinical evaluation.;The patient's willingness to undergo the same surgery again if needed. Timepoint: on day 7 post surgical. Method of measurement: Patient-reported Visual Analogue Scale.;Postoperative discomfort and Inability to chew. Timepoint: on day 7 post surgical. Method of measurement: Patient-reported Visual Analogue Scale.;Gingival graft dimensions (length, width, thickness). Timepoint: after harvesting the graft from palatal site. Method of measurement: Using a periodontal probe (in millimeters).;Palatal soft tissue thickness at the mesial, distal, and central parts of the designated graft site. Timepoint: during surgical process before harvesting the graft from palatal site. Method of measurement: Using a local anesthesia needle with a stopper and a gauge accurate to 0.1 mm. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMoein Khojaste
Mashhad University of Medical Sciences
Outcome results
None listed